本发明公开了一种姜酚肟在制备抗血小板聚集药物中的应用。
The present invention discloses the application of gingerol oxime in preparing platelet aggregation inhibitor.
因此，无出血性疾病的患者，最好长期使用阿司匹林等抗血小板聚集药物，以防止心血管事件的发生。
Therefore, the non-hemorrhagic disease's patient, the best long-term use aspirin and so on anti-blood platelet accumulation medicine, prevents the cardiovascular event's occurrence.
本文介绍了抗血小板聚集药物的研究概况，并对抗血小板药物帕米格雷的药代动力学和药效学特征作了简要综述。
The development of anti-platelet agents was described in this paper. Pamicogrel, a new anti-platelet drug, was introduced in detail, including its pharmacokinetics and pharmacodynamics.
应用推荐